Table 1.
Demographic and clinical characteristics in patients undergoing THA
| na | Total | Vitamin D status |
||||
|---|---|---|---|---|---|---|
| Deficient <50 nmol/L | Insufficient 50–75 nmol/L | Sufficient >75 nmol/L | ||||
| Number of patients | 87 (100) | 23 (26.4) | 32 (36.8) | 32 (36.8) | ||
| Gender, female | 66 (75.9) | 19 (82.6) | 21 (65.6) | 26 (81.3) | ||
| Age, years | 74 (68–79) | 76 (71–82) | 72 (68–77) | 74 (67–79) | ||
| BMIb, kg/m2 | 26 (24–28) | 27 (26–29) | 27 (24–29) | 25 (23–26) | ||
| Comorbidities, yes | 80 | 54 (67.5) | 14 (70.0) | 22 (73.3) | 18 (60.0) | |
| Surgery type | 85 | |||||
| THA | 27 (31.8) | 9 (39.1) | 11 (34.4) | 7 (23.3) | ||
| THA AMIS | 53 (62.4) | 12 (52.2) | 19 (59.4) | 22 (73.3) | ||
| Other | 5 (5.9) | 2 (8.7) | 2 (6.3) | 1 (3.3) | ||
| Physical therapy, yes | 85 | 18 (21.2) | 6 (28.6) | 3 (9.4) | 9 (28.1) | |
| 25(OH)D3c, nmol/L | 68.1±30.11 | 33.6±10.18 | 61.2±6.73 | 99.7±20.79 | ||
| Vitamin D supplementation, yes | 75 | 30 (40.0) | 3 (17.6) | 14 (48.3) | 13 (44.8) | |
Values are presented as mean ± SD, median (IQR) or n (%).
a
(n = 87) unless otherwise specified; bp = 0.010; cp < 0.001.
THA, total hip arthroplasty; BMI, body mass index; AMIS, anterior minimally invasive surgery; 25(OH)D3, 25-hyroxyvitamin D3.